Clinical trial
Acceptability Across Two Time Periods of a SARS-CoV-2 Vaccine Among a Representative Sample of Adults Within the United States
NCT04703790 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acceptability Across Two Time Periods of a SARS-CoV-2 Vaccine Among a Representative Sample of Adults Within the United States
- Lead sponsor
- Columbia University
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 7, 2021
- Completion date
- February 18, 2022
- Enrollment
- 1,208 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, vaccine acceptability